Analyst Day 2025 November 20, 2025 © 2025 Moderna, Inc. All rights reserved. Forward-looking statements and disclaimer This presentation contains forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, as amended, including statements regarding: Moderna's anticipated commercial growth drivers, including geographic expansion and new product launches; Moderna's ability to achieve up to 10% revenue growth in 2026; Moderna's ability to expand its seasonal vaccine f ...